The study found that those with a history of heart inflammation can safely receive Pfizer’s COVID-19 vaccine, despite the risks.
- A new study has found that people who have been hospitalized with heart inflammation in the past five years can safely receive the Pfizer Covid vaccine.
- Concerns about myocarditis and pericarditis after Pfizer vaccination are well documented, especially among young men.
- The CDC warns of the risk of heart inflammation, but still recommends the vaccine to anyone who can get it.
- Previous research has shown that the vaccine reduces the risk of heart inflammation by 85% than infection from the virus itself.
A new study has shown that those with a history of myocarditis and other conditions associated with inflammation of the heart can safely receive Pfizer’s COVID-19 vaccine.
A French research team from the University Hospital of Lyon, about 250 miles southeast of Paris, presented their findings at the European Society of Cardiology Conference on Cardiovascular Emergency, NBC reports.
The results are awaiting peer review for publication in a medical journal.
There is a widely publicized risk of developing heart inflammation as a result of receiving the Pfizer vaccine, especially young men.
The researchers hope these fears won’t turn people away from the injection, which has become the most popular in America and much of the Western world.
Researchers have found that people who have been hospitalized with heart inflammation in the past five years are still safe to receive the Pfizer vaccine, despite concerns about myocarditis or pericarditis.
‘One of [the] The reason that prompted us to conduct this study was a patient with prior myocarditis who refused Covid vaccination for fear of relapse,” study lead author Dr. Abu Saleh told NBC.
The researchers collected data on 55 French patients who were hospitalized for heart inflammation over the past five years.
They have each also received a COVID-19 vaccine at some point since it became available in 2020. Nearly everyone has been vaccinated by Pfizer.
None of the study participants developed heart inflammation again after vaccination.
Myocarditis or pericarditis, the two types of heart inflammation most commonly associated with vaccines, are relatively mild conditions.
It usually resolves on its own after a few days of rest and with limited medical attention.
However, experts still advise people to seek medical attention if they do experience symptoms.
They can be fatal if the person suffering from this disease engages in strenuous physical activity.
In June, the Centers for Disease Control and Prevention (CDC) issued a warning that young people, particularly those who are vaccinated against Pfizer or Moderna Covid, are at risk of developing the disease.
The CDC has warned that recipients of mRNA vaccines, Pfizer and Moderna vaccines, especially young men, are at risk of developing myocarditis. However, the risk of this condition is much higher for people infected with the virus.
A study by the National Institutes of Health found that 70 out of every million men aged 12 to 15 who received the Pfizer vaccine develop myocarditis.
In men aged 16 and 17, 105 per million develop the disease.
However, officials are still recommending that people get vaccinated, as the risk of myocarditis from the shot is 85 percent lower than from contracting Covid.
Although the French study did include several participants who received the Moderna vaccine, the sample size for the group was not large enough for the researchers to draw a definitive conclusion.
However, none of the Moderna recipients in the study who developed heart inflammation in the past also had problems with the vaccine.
Health officials have found that the risk of heart inflammation is slightly higher with Moderna than with Pfizer, although it is still significantly lower than the risk from the virus itself.